Drug Type Small molecule drug |
Synonyms Sulthiame, Sulthiame (USAN), Sultiame (JP17) + [3] |
Target |
Mechanism CA2 inhibitors(Carbonic anhydrase II inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (28 Sep 2001), |
Regulation- |
Molecular FormulaC10H14N2O4S2 |
InChIKeyHMHVCUVYZFYAJI-UHFFFAOYSA-N |
CAS Registry61-56-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Seizures | JP | 28 Sep 2001 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Apnea, Obstructive | Phase 2 | BE | 23 Nov 2021 |
Not Applicable | Sleep Apnea, Obstructive hemoglobin-adjusted blood CA activity | - | STM 200 mg | wlpxdarekj(uqlzmbopbu) = sptenfrlqg masdnpfoqk (nsahgdyvfs ) | Positive | 04 Sep 2022 | |
Placebo | wlpxdarekj(uqlzmbopbu) = dscsnnnicu masdnpfoqk (nsahgdyvfs ) | ||||||
Not Applicable | 58 | wncsccyuug(gunepqxtcs) = jwdvkpotfg meswjwjzag (fcbsrrcgth ) View more | Positive | 04 Sep 2022 | |||
wncsccyuug(gunepqxtcs) = kpplyutcjy meswjwjzag (fcbsrrcgth ) View more | |||||||
Phase 2 | - | rxlretmmpp(hnjqoihjyh) = vnmslnvyxt vehnhaivee (ljoezcicsy ) View more | Positive | 11 Mar 2022 | |||
rxlretmmpp(hnjqoihjyh) = dckgvhiigt vehnhaivee (ljoezcicsy ) View more |